F. Détrée

893 citations
6 papers · 428 indexed · h-index 4

Impact in

Papers in

F. Détrée

6 papers receiving 407 citations

Peers

F. Détrée
Comparison fields: 5 of 42
  • Rheumatology 184
  • Pulmonary and Respiratory Medicine 365
  • Genetics 100
  • Physiology 167
  • Nephrology 45
Replace B. Nölle with:
B. Nölle Germany
Martin Lockwood United Kingdom
Alexander Natusch Germany
DeRemee Ra United States
Loïc Guillevin France
Kent A. Huston United States
H Kraft Germany
M. André France
N Maiden United Kingdom
A. Zoulim France
F. Détrée relative to B. Nölle Germany B. Nölle's profile →
Citations per field
00.5×4.5×
B. Nölle · 1×
Citations per year

Countries citing papers authored by F. Détrée

Since Specialization
Citations

This map shows the geographic impact of F. Détrée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Détrée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Détrée more than expected).

Fields of papers citing papers by F. Détrée

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Détrée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Détrée. The network helps show where F. Détrée may publish in the future.

Co-authors

The 25 scholars most cited alongside F. Détrée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F. Détrée Line = papers co-authored together F. Détrée links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1 1997350
2
Infliximab or rituximab for refractory Wegener's granulomatosis: long-term follow up. A prospective randomised multicentre study on 17 patients.
201161
3 19967
4
[Rhabdomyolysis complicating acute lumbar compartment syndrome].
19945
5
[Algodystrophy of the knee and scanography].
19873
6
[Carriage of HBs antigen in pregnant women and spread of the virus in their family].
19852

About F. Détrée

F. Détrée is a scholar working on Periodontics, Rheumatology, Emergency Medicine, Epidemiology and Physiology, having authored 6 papers that have together received 428 indexed citations. Recurring topics across this work include Vasculitis and related conditions (2 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Sarcoidosis and Beryllium Toxicity Research (1 paper), Autoimmune and Inflammatory Disorders (1 paper), Cancer Diagnosis and Treatment (1 paper), Poisoning and overdose treatments (1 paper), Pharmacological Effects and Toxicity Studies (1 paper) and Musculoskeletal synovial abnormalities and treatments (1 paper). The work is most often cited by research in Rheumatology (184 citations), Pulmonary and Respiratory Medicine (365 citations), Genetics (100 citations), Physiology (167 citations) and Nephrology (45 citations). F. Détrée has collaborated with scholars based in France. Frequent co-authors include Loı̈c Guillevin, Pascal Cohen, C Seigneuric, Isabelle Royer, F. Lhote, M. Stern, Dominique Jacomy, M. Longy‐Boursier, Pascal Bindi and C. Jacquot. Their work appears in journals such as La Revue de Médecine Interne, Arthritis & Rheumatism and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026